UnitedHealth's latest quarter cleared Wall Street's bar. Adjusted EPS came in at $4.69, ahead of the average analyst call. Results got a lift from $610 million that had been earmarked for claims but ultimately wasn't needed. Both core businesses - UnitedHealthcare's insurance arm and Optum's services division - beat expectations on revenue and operating profit, aided by medical expenses consuming a smaller share of premium dollars than anticipated.
Off that momentum, management raised full-year adjusted EPS guidance to at least $20.50, up from $19.50 to $20. Shares jumped as much as 5.6% at the open in New York, the biggest intraday move since July, before easing back. As the first big healthcare conglomerate to post third-quarter numbers, the print offers an early read on the group. Morgan Stanley's team wrote the report "should further rebuild management credibility and reinforce expectations for consistent beats and raises going forward."
"Trend remains elevated but is very stable," Chief Financial Officer Wayne DeVeydt said, describing the rate at which healthcare costs are increasing. He called the at-least-$20.50 target "a solid run rate on which to grow," and suggested the current 2027 consensus may be light. The company projects next year's per-share earnings growth to begin near the bottom of its 13% to 16% target band.
Company leaders reported brisk sales for 2027 across insurance and pharmacy benefit management. Optum Rx now manages drug benefits for more patients at outside health plans than for UnitedHealthcare itself for the first time, Optum CEO Patrick Conway told analysts.
Raised guidance mid-year is a strong signal about underlying demand. Market Briefs covers healthcare free every morning.
UnitedHealth is still reshaping the portfolio after misjudging medical costs last year, dialing back in Medicare Advantage and working with private equity on some physician practices. More uncertainty arrives next year with additional uncertainty looms next year due to shifts in federal rules, including Medicaid work requirements.
After new government rules compressed margins, UnitedHealth moved to reduce its Optum Health clinic footprint by about 20% - roughly 550 locations - starting early this year. Most of that downsizing happened in the first half, and the company expects to finish the process by the end of 2026, according to DeVeydt. The plan is to transition sites to new owners rather than shut them.
"We have no plans to just close any at this stage," he said. Optum Health's operating earnings are set to exceed $2.2 billion this year, in line with earlier messaging that it would be at least that figure.
Medicare Advantage has gotten tougher as medical inflation bites and Washington steps up scrutiny of billing it considers improper. Last week, federal officials cut quality ratings on some UnitedHealthcare plans, a hit that Evercore ISI and TD Cowen analysts estimate could reduce 2028 revenue by more than $1 billion. Across the industry, carriers are closing plans and trimming benefits to protect profitability, which means millions of seniors will be shopping for new coverage next year.
Since the end of 2025, UnitedHealthcare has removed 935,000 seniors from Medicare Advantage and associated programs. Even so, DeVeydt left the door open to a rebound. "Is growth on the table?" he said. "We believe it is."
UnitedHealth's beat and fresh guidance floor show the business grinding back to form, supported by steadier cost trends, a helpful reserve tailwind, and solid execution across insurance and Optum. The flip side is clear too: Medicare Advantage remains a swing factor, and recent ratings changes could pinch 2028 revenue.
For everyday investors tracking the story, watch the new $20.50 minimum for this year, how the clinic reshuffle progresses, Optum's momentum with external clients, and how next year's Medicare Advantage changes filter into enrollment and margins.
Insurer margins reveal what is happening to medical costs. Get the free Market Briefs daily newsletter and follow it.
